These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22447093)

  • 21. [Depressive disorders in panic attack patients and their correction with escitalopram].
    Levada OA; Cherednichenko NV
    Lik Sprava; 2005; (5-6):77-80. PubMed ID: 16396301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study.
    Perlis RH; Purcell S; Fava M; Fagerness J; Rush AJ; Trivedi MH; Smoller JW
    Arch Gen Psychiatry; 2007 Jun; 64(6):689-97. PubMed ID: 17548750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of escitalopram on metabolic parameters in patients with major depressive disorder, generalised anxiety disorder, and panic disorder: a prospective 6-month follow-up study.
    Peh AL; Nieng CH; Ling YH; Kheng TW; Neng TS; Koon OG
    Asian J Psychiatr; 2013 Jun; 6(3):256-7. PubMed ID: 23642988
    [No Abstract]   [Full Text] [Related]  

  • 24. Agomelatine reversal of escitalopram-induced apathy: a case report.
    De Berardis D; Valchera A; Fornaro M; Serroni N; Marini S; Moschetta FS; Martinotti G; Di Giannantonio M
    Psychiatry Clin Neurosci; 2013 Apr; 67(3):190-1. PubMed ID: 23581873
    [No Abstract]   [Full Text] [Related]  

  • 25. Escitalopram in major depressive disorder: a multicenter, randomized, double-blind, fixed-dose, parallel trial in a Chinese population.
    Mao PX; Tang YL; Jiang F; Shu L; Gu X; Li M; Qian M; Ma C; Mitchell PB; Cai ZJ
    Depress Anxiety; 2008; 25(1):46-54. PubMed ID: 17149753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The treatment of SSRI-resistant depression in adolescents (TORDIA): in search of the best next step.
    Brent DA
    Depress Anxiety; 2009; 26(10):871-4. PubMed ID: 19798756
    [No Abstract]   [Full Text] [Related]  

  • 27. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
    Pelissolo A
    Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.
    Trivedi MH; Rush AJ; Wisniewski SR; Nierenberg AA; Warden D; Ritz L; Norquist G; Howland RH; Lebowitz B; McGrath PJ; Shores-Wilson K; Biggs MM; Balasubramani GK; Fava M;
    Am J Psychiatry; 2006 Jan; 163(1):28-40. PubMed ID: 16390886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interpersonal psychotherapy for depression with panic spectrum symptoms: a pilot study.
    Cyranowski JM; Frank E; Shear MK; Swartz H; Fagiolini A; Scott J; Kupfer DJ
    Depress Anxiety; 2005; 21(3):140-2. PubMed ID: 15965998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neonatal morbidity due to maternal use of two antidepressant drugs.
    Jwa S; Wada Y; Yamamoto M; Sumida Y
    Pediatr Int; 2018 Jan; 60(1):87-88. PubMed ID: 29235219
    [No Abstract]   [Full Text] [Related]  

  • 31. Hypomania induced by escitalopram: 2 case reports.
    Sharma RC
    Psychopharmacol Bull; 2009; 42(2):89-91. PubMed ID: 19629025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inappropriate antidiuretic hormone secretion and rhabdomyolysis associated with citalopram.
    Zullino D; Brauchli S; Horvath A; Baumann P
    Therapie; 2000; 55(5):651-2. PubMed ID: 11201982
    [No Abstract]   [Full Text] [Related]  

  • 33. Interactive case conference. First episode: depression and panic disorder.
    Dunner DL
    CNS Spectr; 2005 Sep; 10(9):696-7. PubMed ID: 16142209
    [No Abstract]   [Full Text] [Related]  

  • 34. Successful treatment of salbutamol-induced panic disorder with citalopram.
    Rihmer Z
    Eur Neuropsychopharmacol; 1997 Aug; 7(3):241-2. PubMed ID: 9213085
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of pharmacotherapy on personality disorders in panic disorder: a one year naturalistic study.
    Marchesi C; Cantoni A; Fontò S; Giannelli MR; Maggini C
    J Affect Disord; 2005 Dec; 89(1-3):189-94. PubMed ID: 16209891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delirium during i. v. citalopram treatment: a case report.
    Delić M; Pregelj P
    Pharmacopsychiatry; 2013 Jan; 46(1):37-8. PubMed ID: 22821385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial.
    Stahl SM; Gergel I; Li D
    J Clin Psychiatry; 2003 Nov; 64(11):1322-7. PubMed ID: 14658946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical effectiveness and safety of citalopram in patients with depression after myocardial infarction].
    Pogosova GV; Zhidko NI; Mikheeva TG; Baĭchorov IKh
    Kardiologiia; 2003; 43(1):24-9. PubMed ID: 12891283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Citalopram: new indication. No advantage.
    Prescrire Int; 1999 Feb; 8(39):18-9. PubMed ID: 10557570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of citalopram treatment on relationship between platelet serotonin functions and the Karolinska scales of personality in panic patients.
    Neuger J; Wistedt B; Aberg-Wistedt A; Stain-Malmgren R
    J Clin Psychopharmacol; 2002 Aug; 22(4):400-5. PubMed ID: 12172340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.